Congress Pushes To Turn Trump’s Psychedelic Therapy Order Into Law
A new bipartisan bill would take President Trump’s psychedelic therapy order and try to make it harder to undo.
Read Morelisteo-data-scraper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/healingmaps.imarkdev.com/wp-includes/functions.php on line 6170
A new bipartisan bill would take President Trump’s psychedelic therapy order and try to make it harder to undo.
Read MoreWe see tons of ketamine clinic websites. While a lot of them look great, one little mistake can be the difference between trust and skepticism.
Read More
The DEA rules that power ketamine telemedicine expire December 31. The permanent rules will reshape platforms, prescribing, and referrals.
Read More
The FDA's crackdown on compounded GLP-1 marketing is a preview for ketamine clinics. Your website copy may be your biggest liability.
Read More
Intravenous ketamine reduced suicidal and depressive symptoms quickly, sometimes within hours. That matters.
Read More
A new narrative review argues that ketamine dosing should be rethought. An anesthesia dose, a pain dose and a psychiatric dose are not equal.
Read More
A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive assessment that screens for more than 60 mental health conditions in a single sitting. Patients complete it at home in under an hour. Clinicians receive a structured report showing the likelihood of each condition before […]
Read More
A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic policy.
Read More
A healthcare-specific Google Maps playbook for ketamine clinics — GBP, citations, reviews, and the 5 generic SEO tactics to skip.
Read More
Clinical Trial Vanguard recently examined a tension that sits at the center of psychedelic research right now.
Read More